- Company Overview for SPLICEOR LTD (12826144)
- Filing history for SPLICEOR LTD (12826144)
- People for SPLICEOR LTD (12826144)
- More for SPLICEOR LTD (12826144)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
22 Dec 2023 | AA | Total exemption full accounts made up to 31 August 2023 | |
24 Aug 2023 | CS01 | Confirmation statement made on 19 August 2023 with no updates | |
28 Nov 2022 | AA | Total exemption full accounts made up to 31 August 2022 | |
20 Sep 2022 | AP01 | Appointment of Dr Jonathan Mark Treherne as a director on 15 September 2022 | |
31 Aug 2022 | CS01 | Confirmation statement made on 19 August 2022 with no updates | |
26 Nov 2021 | AA | Total exemption full accounts made up to 31 August 2021 | |
01 Sep 2021 | CS01 | Confirmation statement made on 19 August 2021 with updates | |
01 Sep 2021 | CH01 | Director's details changed for Michael Albert Salako on 19 August 2021 | |
01 Sep 2021 | CH01 | Director's details changed for Dr Carin Kristina Ingemarsdotter on 1 September 2021 | |
16 Jun 2021 | AD01 | Registered office address changed from C/O Milner Therapeutics Institute Jeffrey Cheah Biomedical Centre Puddicombe Way Cambridge CB2 0AW United Kingdom to Salisbury House Station Road Cambridge CB1 2LA on 16 June 2021 | |
28 Apr 2021 | MA | Memorandum and Articles of Association | |
28 Apr 2021 | RESOLUTIONS |
Resolutions
|
|
08 Apr 2021 | SH01 |
Statement of capital following an allotment of shares on 26 March 2021
|
|
08 Apr 2021 | AP01 | Appointment of Michael Albert Salako as a director on 26 March 2021 | |
20 Aug 2020 | NEWINC |
Incorporation
Statement of capital on 2020-08-20
|